Novel Tryptamine Compounds as 5-HT2A Agonists for Treating Mood Disorders such as Depressive Disorders and Bipolar Disorders.
Journal: ACS Medicinal Chemistry Letters
Published:
Abstract
Provided herein are novel tryptamine compounds as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating mood disorders such as depressive disorders and bipolar disorders and processes for preparing such compounds.
Authors
Ram Sabnis, Anika Sabnis
Relevant Conditions